JP2002541802A - チロシンキナーゼ基質（Ｔｋｓ）蛋白質 - Google Patents

チロシンキナーゼ基質（Ｔｋｓ）蛋白質

Info

Publication number
JP2002541802A
JP2002541802A JP2000611673A JP2000611673A JP2002541802A JP 2002541802 A JP2002541802 A JP 2002541802A JP 2000611673 A JP2000611673 A JP 2000611673A JP 2000611673 A JP2000611673 A JP 2000611673A JP 2002541802 A JP2002541802 A JP 2002541802A
Authority
JP
Japan
Prior art keywords
seq
polypeptide
nucleic acid
amino acid
domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000611673A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002541802A5 (enExample
Inventor
ファン，フアン
コートニッジ，サラ・エー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sugen LLC
Original Assignee
Sugen LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sugen LLC filed Critical Sugen LLC
Publication of JP2002541802A publication Critical patent/JP2002541802A/ja
Publication of JP2002541802A5 publication Critical patent/JP2002541802A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Otolaryngology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2000611673A 1999-04-09 2000-04-06 チロシンキナーゼ基質（Ｔｋｓ）蛋白質 Pending JP2002541802A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12849299P 1999-04-09 1999-04-09
US60/128,492 1999-04-09
PCT/US2000/009277 WO2000061750A2 (en) 1999-04-09 2000-04-06 TYROSINE KINASE SUBSTRATE (Tks) PROTEINS

Publications (2)

Publication Number Publication Date
JP2002541802A true JP2002541802A (ja) 2002-12-10
JP2002541802A5 JP2002541802A5 (enExample) 2007-06-07

Family

ID=22435608

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000611673A Pending JP2002541802A (ja) 1999-04-09 2000-04-06 チロシンキナーゼ基質（Ｔｋｓ）蛋白質

Country Status (6)

Country Link
US (1) US20060019294A1 (enExample)
EP (1) EP1175490A2 (enExample)
JP (1) JP2002541802A (enExample)
AU (1) AU4211200A (enExample)
CA (1) CA2365623A1 (enExample)
WO (1) WO2000061750A2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009271335B2 (en) * 2008-06-23 2015-06-25 Revvity Health Sciences, Inc. Kinase substrates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2217641A1 (en) * 1995-04-07 1996-10-10 Cytogen Corporation Polypeptides having a functional domain of interest and methods of identifying and using same
DE19820190A1 (de) * 1998-04-28 1999-11-04 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Pankreas-Tumor

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
JPN6010009143, ＮＣＢＩ， Ａｃｃｅｓｓｉｏｎ Ｎｏ．ＡＡ７７８２１０， １９９８ ｕｐｌｏａｄｅｄ， ［検索日：２０１０．０２．１６］ *
JPN6010009147, ＮＣＢＩ， Ａｃｃｅｓｓｉｏｎ Ｎｏ．Ｒ１８３８６， １９９５ ｕｐｌｏａｄｅｄ， ［検索日：２０１０．０２．１６］ *
JPN6010009149, ＮＣＢＩ， Ａｃｃｅｓｓｉｏｎ Ｎｏ．Ｗ６５３２９， １９９６ ｕｐｌｏａｄｅｄ， ［検索日：２０１０．０２．１６］ *
JPN6010009152, ＮＣＢＩ， Ａｃｃｅｓｓｉｏｎ Ｎｏ．ＡＡ４０２７３６， １９９６ ｕｐｌｏａｄｅｄ， ［検索日：２０１０．０２．１６］ *
JPN6010009157, ＥＭＢＯ Ｊ， （１９９８）， ｖｏｌ．１７， ｎｏ．１５， ｐ．４３４６−４３５７ *

Also Published As

Publication number Publication date
US20060019294A1 (en) 2006-01-26
WO2000061750A2 (en) 2000-10-19
WO2000061750A3 (en) 2001-12-06
EP1175490A2 (en) 2002-01-30
WO2000061750A9 (en) 2002-06-20
AU4211200A (en) 2000-11-14
CA2365623A1 (en) 2000-10-19

Similar Documents

Publication Publication Date Title
EP1051500B1 (en) Diagnosis and treatment of aur1 and/or aur2 related disorders
EP1073723B1 (en) Ste20-related protein kinases
US20060234344A1 (en) Protein kinases
CA2377662A1 (en) Novel protein phosphatases and diagnosis and treatment of phosphatase-related disorders
EP0960203A1 (en) Mammalian chk1 effector cell-cycle checkpoint protein kinase materials and methods
CA2331889A1 (en) Nek-related and bub1-related protein kinases
US6495353B1 (en) Human orthologues of wart
US7119174B2 (en) Diagnosis and treatment of AUR1 and/or AUR2 related disorders
US20080009610A1 (en) Diagnosis and treatment of PTP related disorders
US7029912B1 (en) Tyrosine kinase substrate(Tks) proteins
US20050026184A1 (en) Diagnosis and treatment of alk-7 related disorders
US6844177B2 (en) Diagnosis and treatment of PTP04 related disorders
US20060019294A1 (en) Tyrosine kinase substrate (Tks) proteins
US5895813A (en) Diagnosis and treatment of TKA-1 related disorders
EP1533378A2 (en) Tyrosine kinase substrate protein Tks7
JP2003510010A (ja) Ｐｙｋ２結合蛋白質
US6342593B1 (en) Diagnosis and treatment of ALP related disorders
EP1595946A2 (en) STE20-related protein kinases

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070405

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070405

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20091020

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20091020

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100219

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100518

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100525

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20101013